ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.2710C>T (p.Arg904Cys)

dbSNP: rs727503253
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Cardiomyopathy Variant Curation Expert Panel RCV000208124 SCV001976461 pathogenic Primary dilated cardiomyopathy 2021-09-27 reviewed by expert panel curation The NM_000257.4:c.2710C>T (p.Arg904Cys) variant in MYH7 has been identified in 4 individuals with DCM in the literature (1 of whom also had LVNC; van Spaendonck-Zwarts 2013 PMID:23349452; van der Zwaag 2011 PMID:20573160; Walsh 2017 PMID:27532257; Miller 2017 PMID29212898) and 3 individuals with LVNC (2 of which were pediatric; Yang 2014 PMID:25326635; Wang 2017 PMID:28855170; van Waning 2018 PMID:29447731). This variant was identified in 8 individuals with DCM and 1 proband with LVNC by clinical laboratories (GeneDx pers. comm.; Invitae pers. comm.; LMM pers. comm.; OMGL pers comm.). Only probands with DCM are counted towards PS4 (n=12; PS4_Moderate). This variant segregated with DCM in 15 affected individuals from 4 families (PP1_Strong; van der Zwaag 2011 PMID:20573160; GeneDx pers. comm.; LMM pers. comm.; OMGL pers. comm.) and was assumed de novo in 1 of the above cases (PM6; GeneDx pers. comm.). This variant has been identified in 0.010% (1/10080) of Ashkenazi Jewish chromosomes by gnomAD v2.1.1 (https://gnomad.broadinstitute.org), but was absent from all other populations. A different pathogenic missense variant has been previously identified at this codon, which indicates that this residue may be critical to the function of the protein (PM5; c.2711G>A p.Arg904His - Variation ID 42926). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for dilated cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (Kelly 2018 PMID:29300372): PS4_Moderate, PP1_Strong, PM6, PM2, PM5, PP3.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000208124 SCV000199172 pathogenic Primary dilated cardiomyopathy 2018-01-19 criteria provided, single submitter clinical testing The p.Arg904Cys variant in MYH7 has been identified in at least 4 individuals wi th DCM and segregated with disease in 11 affected relatives from 2 families (van der Zwaag 2011; Miller 2017; LMM data). It has also been identified in 1/9850 o f Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http: //gnomad.broadinstitute.org; dbSNP rs727503253). Arginine (Arg) at position 904 is highly conserved in mammals and across evolutionarily distant species and the change to cysteine (Cys) was predicted to be pathogenic using a computational t ool clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). Of note, this variant li es in the head region of the protein. Missense variants in this region have been reported and statistically indicated to be more likely to cause disease (Walsh 2016). In summary, this variant meets criteria to be classified as pathogenic fo r dilated cardiomyopathy in an autosomal dominant manner based upon segregation studies, low frequency in controls, and predicted functional impact. ACMG/AMP Cr iteria applied: PP1_Strong; PM1; PM2; PP3; PS4_Supporting.
Blueprint Genetics RCV000208124 SCV000264083 pathogenic Primary dilated cardiomyopathy 2015-11-10 criteria provided, single submitter clinical testing
Center for Medical Genetics Ghent, University of Ghent RCV000240635 SCV000299238 pathogenic Dilated cardiomyopathy 1S 2016-02-18 criteria provided, single submitter clinical testing
Baylor Genetics RCV000240635 SCV000807278 pathogenic Dilated cardiomyopathy 1S criteria provided, single submitter clinical testing
Invitae RCV000685493 SCV000812976 pathogenic Hypertrophic cardiomyopathy 2024-01-20 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 904 of the MYH7 protein (p.Arg904Cys). This variant is present in population databases (rs727503253, gnomAD 0.01%). This missense change has been observed in individuals with dilated cardiomyopathy (PMID: 20573160, 23349452, 28855170, 29212898, 29447731; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 164316). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg904 amino acid residue in MYH7. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21750094, 22464770, 25448463; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine RCV001537865 SCV001754770 pathogenic Hypertrophic cardiomyopathy 1 2019-07-24 criteria provided, single submitter clinical testing The c.2710C>T variant in the MYH7 gene changes the arginine to a cysteine at codon 904 in the resultant protein (p.Arg904Cys). This codon lies within an important functional domain of MYH7 (amino acids 181-937). It is an evolutionarily conserved location and in-silico tools predict this change to be damaging. This particular variant has been reported in multiple individuals with dilated cardiomyopathy and segregates within families (PMID: 27532257, 20573160). In addition, a different missense substitution at this same codon (p.Arg904His) is considered pathogenic. It is an extremely rare variant having been seen in 1/251442 (0.000398%) individuals in gnomAD. According to ClinGen's Inherited Cardiomyopathy Expert Panel guidelines for interpretation of MYH7 (PMID: 29300372), this variant is considered pathogenic.
Ambry Genetics RCV002426717 SCV002740992 pathogenic Cardiovascular phenotype 2020-07-09 criteria provided, single submitter clinical testing The p.R904C pathogenic mutation (also known as c.2710C>T), located in coding exon 21 of the MYH7 gene, results from a C to T substitution at nucleotide position 2710. The arginine at codon 904 is replaced by cysteine, an amino acid with highly dissimilar properties and is located in the head (motor) domain of the protein. This variant was reported to segregate with disease in a large, multi-generational family with multiple members diagnosed with dilated cardiomyopathy (DCM) (van der Zwaag PA et al. Clin. Genet., 2011 May;79:459-67). Additionally, this variant has been reported in various cohorts of individuals diagnosed with DCM or left ventricular non-compaction (LVNC), however clinical data was limited (Wang C et al. J Am Heart Assoc, 2017 Aug;6(9); Miller EM et al. Circ Cardiovasc Genet, 2017 Dec;10(6); van Waning JI et al. J. Am. Coll. Cardiol., 2018 02;71:711-722). An alternate amino acid substitution at this position, p.R409H, has been reported in individual(s) with dilated cardiomyopathy (Waldmüller S et al. Eur. J. Heart Fail., 2011 Nov;13:1185-92). In addition to the clinical data presented in the literature, this amino acid position is highly conserved in available vertebrate species. Furthermore, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.